Dr Gabriel Funingana

Gabriel Funingana MD is a medical oncologist and clinical academic focused on advancing precision cancer medicine through molecular oncology, biomarker development, and the clinical implementation of genomic technologies. He is a Clinical Research Training Fellow and PhD student at the University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, supported by The Mark Foundation Institute for Integrative Cancer Medicine.

Gabriel’s work sits at the interface of pan-cancer genomics, translational oncology, and clinical decision-making. He has contributed to first-in-human and first-in-class clinical trials, as well as personalised medicine studies designed to match patients to therapies based on the molecular characteristics of their tumours. His current research explores how whole-genome sequencing and AI-enabled decision-support tools can be embedded into clinical pathways to improve treatment selection and patient outcomes.